Clinical Report: Scientists Extract Genomes from 1930s Tumors

Overview

Researchers have successfully extracted usable genetic information from colorectal cancer samples dating back to 1932 using advanced DNA techniques. This innovative approach may enhance the understanding of disease evolution and microbiome changes over time.

Background

The ability to analyze historical tumor specimens is crucial for understanding the evolution of diseases like cancer. Traditional genomic analyses are limited to recent samples, which restricts insights into long-term trends. By adapting ancient DNA techniques, researchers can now explore genetic information from archived formalin-fixed paraffin-embedded (FFPE) tissues, overcoming challenges posed by DNA degradation and potentially transforming historical pathology archives into valuable genomic resources.

Data Highlights

Key Findings

• Successful extraction of DNA from colorectal cancer samples collected between 1932 and 2023.
• Optimized methods for deparaffinization and DNA extraction enabled the recovery of highly fragmented DNA.
• Application of whole-genome sequencing and targeted cancer gene panels modified for older specimens.
• Detection of both expected gut bacteria and previously linked microbial species associated with colorectal cancer.
• Potential for the method to be applied to other diseases beyond colorectal cancer.

Clinical Implications

This study highlights the potential for utilizing archived specimens to gain insights into historical disease patterns and microbiome changes. Clinicians may consider the implications of evolving tumor biology in their diagnostic practices and research, particularly in understanding how historical trends inform current treatment strategies.

Conclusion

The adaptation of ancient DNA techniques for genomic analysis of historical tumor specimens represents a significant advancement in pathology. This approach may provide critical insights into the evolution of cancer and its associated microbiome over decades, offering a new perspective on historical disease patterns.

References

1. Acta Neuropathologica, 2017 -- Rapid Genomic and Epigenomic Assessment of Brain Tumors via Real-Time Nanopore Sequencing
2. Blood Cancer Journal, 2013 -- Insights Gained from Next-Generation Sequencing in Blood Cancers
3. The ASCO Post, 2011 -- Genomic Researchers Identify Weak Points in Breast Cancer Cells
4. Acta Neuropathologica, 2024 -- HOXD12 Characterizes a Subtype of Oligodendroglioma with Aggressive Features Linked to Age
5. PubMed, 2024 -- Recommendations for Tumor Mutational Burden Assay Validation and Reporting
6. Nature Communications, 2025 -- Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
7. Biospecimen Research Database, 2025 -- Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer
8. Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer - PubMed
9. Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology | Nature Communications
10. Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis - Biospecimen Research Database